Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leveraging Immunotherapy For Tumor Downstaging to Milan Criteria in Patients With Hepatocellular Carcinoma

NCT07489976 is registered in ClinicalTrials.gov with Ju Dong Yang as lead sponsor.

NCT NCT07489976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07489976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leveraging Immunotherapy For Tumor Downstaging to Milan Criteria in Patients With Hepatocellular Carcinoma
Lead sponsor
Ju Dong Yang
Phase
Phase 2
Overall status
Recruiting
Start date
April 1, 2026
Completion date
December 31, 2030
Enrollment
41 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepato cellular carcinoma